A case of T-cell lymphoproliferative disorder associated with hypereosinophilia with excellent response to mycophenolate mofetil.

Citation data:

Hematology/oncology and stem cell therapy, ISSN: 1658-3876

Publication Year:
2017
Captures 4
Readers 4
Social Media 72
Tweets 72
Citations 2
Citation Indexes 2
PMID:
28174010
DOI:
10.1016/j.hemonc.2016.11.001
Author(s):
Hanbali, Amr; Shaheen, Marwan; Alfraih, Feras; Al-Otaibi, Wafa; El Fakih, Riad; Owaidah, Tarek; Ahmed, Syed
Publisher(s):
Elsevier BV
Most Recent Tweet View All Tweets
article description
Hypereosinophilic syndrome (HES) is a group of rare blood disorders characterized by a persistent elevation of blood eosinophil count ⩾1.5×10/L and clinical manifestations attributable to eosinophilia or tissue hypereosinophilia. Lymphocytic variant of HES (HES-L) is a known subtype according to World Health Organization classification. It is well documented in the literature that patients with HES-L are predisposed to develop T-cell lymphoma. We report a case of T-cell lymphoproliferation associated with hypereosinophilia, which has been successfully treated with mycophenolate mofetil, with resolution of skin lesions and normalization of eosinophil count and immunoglobulin E level. We believe this is a clinically relevant case since this is a rare disease with little known knowledge on its best treatment modality.